KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 2,615.00
0.00 (0.00%)
At close: Nov 6, 2026
KoBioLabs Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 75,409 | 69,292 | 68,359 | 33,138 | 11,606 | 2,893 |
Revenue Growth | 8.54% | 1.36% | 106.29% | 185.53% | 301.12% | -36.98% |
Gross Profit Gross Profit Growth | 56,491 | 51,025 | 46,794 | 23,709 | 7,979 | 1,898 |
Operating Income Operating Income Growth | -8,067 | -9,651 | -6,905 | -18,458 | -20,292 | -16,337 |
Net Income Net Income Growth | -4,804 | -6,330 | -5,298 | -13,853 | -21,921 | -15,382 |
Earnings Per Share EPS Growth | -247.39 | -326.14 | -276.18 | -748.00 | -1305.15 | -959.00 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 75,230 | 69,199 | 68,093 | 32,574 | 10,672 | 2,668 |
Overseas Overseas Growth | 179.42 | 92.29 | 265.25 | 564.22 | 933.81 | 225.2 |
Total Total Growth | 75,409 | 69,292 | 68,359 | 33,138 | 11,606 | 2,893 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 48,165 | 47,100 | 55,830 | 66,240 | 92,947 | 88,685 |
Total Debt Total Debt Growth | 16,782 | 13,769 | 16,540 | 18,294 | 13,782 | 9,197 |
Net Cash (Debt) Net Cash Growth | 31,383 | 33,331 | 39,290 | 47,946 | 79,165 | 79,488 |
Net Cash Growth | -12.04% | -15.17% | -18.05% | -39.43% | -0.41% | 56.20% |
Net Cash Per Share Net Cash Per Share Growth | 1616.10 | 1717.36 | 2048.20 | 2587.95 | 4713.30 | 4953.80 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2,446 | -5,784 | -4,355 | -13,832 | -16,556 | -12,481 |
Capital Expenditures CapEx Growth | -404.15 | -296.78 | -1,640 | -15,133 | -14,683 | -5,512 |
Free Cash Flow Free Cash Flow Growth | -2,851 | -6,081 | -5,995 | -28,966 | -31,239 | -17,993 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.91% | 73.64% | 68.45% | 71.55% | 68.75% | 65.61% |
Operating Margin | -10.70% | -13.93% | -10.10% | -55.70% | -174.84% | -564.66% |
Pretax Margin | -6.29% | -10.02% | -6.11% | -44.31% | -198.44% | -565.72% |
Profit Margin | -6.37% | -9.13% | -7.75% | -41.80% | -188.89% | -531.63% |
FCF Margin | -3.78% | -8.78% | -8.77% | -87.41% | -269.17% | -621.88% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.67 | 1.61 | 1.52 | 4.85 | 16.48 | 115.84 |